Identification of breast cancer candidate genes using gene co-expression and protein-protein interaction information

Zhenyu Yue1,2, Hai-Tao Li3, Yabing Yang1

  • 1School of Life Sciences, Anhui University, Hefei, Anhui 230601, China.

Oncotarget
|May 7, 2016
PubMed

Insights

Researchers identified seven key genes associated with breast cancer (BC) using network analysis. A signature based on these genes accurately predicts relapse-free survival in BC patients, offering potential prognostic markers.

Area of Science:

  • Genomics
  • Bioinformatics
  • Molecular Oncology

Background:

  • Breast cancer (BC) remains a leading cause of mortality in women, with its molecular underpinnings incompletely understood.
  • Identifying novel genes linked to BC is crucial for advancing gene function knowledge and discovering therapeutic targets.

Purpose of the Study:

  • To identify novel breast cancer-related genes using computational methods.
  • To develop a gene expression signature for predicting breast cancer patient prognosis.

Main Methods:

  • Subnetwork extraction algorithms were applied to known BC genes (seed genes), gene co-expression data, and protein-protein interaction networks.
  • Seven key genes (EPHX2, GHRH, PPYR1, ALPP, KNG1, GSK3A, TRIT1) were computationally predicted as putative BC genes.
  • An expression signature was constructed using the seven identified genes.

Main Results:

  • Six of the seven predicted genes were previously reported as breast cancer-associated, and one (PPYR1) as cancer-associated.
  • The 7-gene expression signature significantly stratified 1660 BC patients based on relapse-free survival (HR, 0.55; 95% CI, 0.46-0.65; Logrank p = 5.5e-13).

Conclusions:

  • The identified seven genes show promise as novel prognostic and predictive molecular markers for breast cancer.
  • The developed 7-gene signature can serve as a valuable tool for predicting clinical outcomes and disease prognosis in breast cancer patients.